Delivery Order GS07F0446V-AG6538D12AA04

This is a firm fixed price delivery order awarded by the Department of Health and Human Services Food and Drug Administration to Illumina, Inc., a for-profit manufacturer of sequencing and array-based analytical instruments and reagents. The $130,354.54 contract is for the provision of REAGENT (CHEMISTRY) KITS with a completion date of September 14, 2022. Illumina is a well-established provider of genomic sequencing solutions to various federal agencies, including the National Institutes of...

The Department of Health and Human Services Food and Drug Administration awarded a delivery order contract to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents, for the provision of "REAGENT (CHEMISTRY) KITS" on a firm fixed price basis. The contract has a potential value of $322,276.99 and a completion date of September 14, 2022. Illumina has previously provided sequencing instruments, reagents, and supporting services to federal agencies such as the...

This is a firm fixed price delivery order awarded by the Food and Drug Administration (FDA), a civilian agency, to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The contract, valued at $277,984.22, is for the provision of REAGENT (CHEMISTRY) KITS with a period of performance through September 30, 2022. There is no set-aside designation noted. Based on Illumina's background as a provider of genomic sequencing systems and consumables to...

The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The $100,250.08 contract is for the provision of REAGENT (CHEMISTRY) KITS, with an August 29, 2018 completion date. Illumina has a history of providing sequencing systems, consumables, and support services to various federal agencies like the NIH, CDC, USDA, and VA to support...

The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed-price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents, for the provision of "REAGENT (CHEMISTRY) KITS". The contract, valued at $52,069.01, has an end date of October 31, 2022 and does not have any set-aside designation. Illumina has previously provided sequencing instruments, reagents, and bioinformatics products to support genomic...

The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The $38,882.34 contract is for the delivery of REAGENT (CHEMISTRY) KITS, with a performance period ending on September 14, 2022. This award does not have a set-aside designation. Illumina has a history of providing sequencing systems, consumables, and bioinformatics support to...

The NIH Clinical Center awarded a delivery order (26-000767) to Illumina, Inc. for NextSeq 1000/2000 P2 XLEAP-SBS Reagent Kits (300 cycles) on December 23, 2025, with a ceiling value of $149,192.82 and a firm fixed price structure. This is a non-set-aside contract with performance completion targeted for September 30, 2026, and will be fulfilled from Illumina's San Diego, California facility. The delivery order procures specialized sequencing reagent kits designed for use with Illumina's NextSeq...

This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The contract, valued at $93,018.18, is for the provision of REAGENT (CHEMISTRY) KITS and has an ultimate completion date of September 14, 2022. The contract has no set-aside designation. Illumina, a for-profit manufacturer, has provided a range of genomic sequencing systems, reagents, and related products and services...

The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a $156,650.78 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer, for the provision of various sequencing reagents and kits to support the NIH's Center for Cellular Engineering (CCE). This includes NextSeq 500/550 v2.5 sequencing reagent kits, PhiX Control v3 kits, and related technical support. The contract has no set-aside designation and is being issued under...

This is a firm fixed price delivery order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $46,050.32, is for the provision of REAGENT (CHEMISTRY) KITS. Illumina has been a provider of sequencing systems, reagents, and associated products and services to various federal agencies including the NIH, CDC, USDA, and VA. This award does not include a set-aside...